121 related articles for article (PubMed ID: 21736709)
1. A 5'-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A.
Colombo F; Falvella FS; Galvan A; Frullanti E; Kunitoh H; Ushijima T; Dragani TA
Mol Cancer; 2011 Jul; 10():81. PubMed ID: 21736709
[TBL] [Abstract][Full Text] [Related]
2. MFSD2A is a novel lung tumor suppressor gene modulating cell cycle and matrix attachment.
Spinola M; Falvella FS; Colombo F; Sullivan JP; Shames DS; Girard L; Spessotto P; Minna JD; Dragani TA
Mol Cancer; 2010 Mar; 9():62. PubMed ID: 20236515
[TBL] [Abstract][Full Text] [Related]
3. Putative association of the single nucleotide polymorphisms in RASSF1A promoter with Korean lung cancer.
Sung JS; Han SG; Whang YM; Shin ES; Lee JW; Lee HJ; Ryu JS; Choi IK; Park KH; Kim JS; Shin SW; Chu EK; Kim YH
Lung Cancer; 2008 Sep; 61(3):301-8. PubMed ID: 18313166
[TBL] [Abstract][Full Text] [Related]
4. The two single nucleotide polymorphisms in the H37/RBM5 tumour suppressor gene at 3p21.3 correlated with different subtypes of non-small cell lung cancers.
Oh JJ; Koegel AK; Phan DT; Razfar A; Slamon DJ
Lung Cancer; 2007 Oct; 58(1):7-14. PubMed ID: 17606309
[TBL] [Abstract][Full Text] [Related]
5. Association of polymorphisms and haplotype in the region of TRIT1, MYCL1 and MFSD2A with the risk and clinicopathological features of gastric cancer in a southeast Chinese population.
Chen S; Zheng Z; Tang J; Lin X; Wang X; Lin J
Carcinogenesis; 2013 May; 34(5):1018-24. PubMed ID: 23349019
[TBL] [Abstract][Full Text] [Related]
6. [Association of two genetic polymorphisms in the 5'untranslated region of exon 2 of the p73 gene and risk of lung cancer].
Hu ZB; Miao XP; Ma HX; Tan W; Niu JY; Lin DX; Shen HB
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Feb; 26(2):106-9. PubMed ID: 15921610
[TBL] [Abstract][Full Text] [Related]
7. C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer.
Shi Y; Chen J; Li Z; Zhang Z; Yu H; Sun K; Wang X; Song X; Wang Y; Zhen Y; Yang T; Lou K; Zhang Y; Zhang G; Hu Y; Ji J; Hui R
Oncogene; 2011 Sep; 30(39):4107-17. PubMed ID: 21499297
[TBL] [Abstract][Full Text] [Related]
8. The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas.
Leng S; Bernauer AM; Hong C; Do KC; Yingling CM; Flores KG; Tessema M; Tellez CS; Willink RP; Burki EA; Picchi MA; Stidley CA; Prados MD; Costello JF; Gilliland FD; Crowell RE; Belinsky SA
Clin Cancer Res; 2011 Apr; 17(7):2014-23. PubMed ID: 21355081
[TBL] [Abstract][Full Text] [Related]
9. Ethnic differences in frequencies of gene polymorphisms in the MYCL1 region and modulation of lung cancer patients' survival.
Spinola M; Falvella FS; Galvan A; Pignatiello C; Leoni VP; Pastorino U; Paroni R; Chen S; Skaug V; Haugen A; Dragani TA
Lung Cancer; 2007 Mar; 55(3):271-7. PubMed ID: 17145094
[TBL] [Abstract][Full Text] [Related]
10. Methylated +322-327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer.
Zeng Y; Zhu J; Qin H; Shen D; Lei Z; Li W; Ding Z; Huang JA; Liu Z
Oncol Rep; 2017 Jul; 38(1):529-537. PubMed ID: 28586012
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of AHR transcription by NF1C is affected by a single-nucleotide polymorphism, and is involved in suppression of human uterine endometrial cancer.
Li D; Takao T; Tsunematsu R; Morokuma S; Fukushima K; Kobayashi H; Saito T; Furue M; Wake N; Asanoma K
Oncogene; 2013 Oct; 32(41):4950-9. PubMed ID: 23208493
[TBL] [Abstract][Full Text] [Related]
12. GCM1 regulation of the expression of syncytin 2 and its cognate receptor MFSD2A in human placenta.
Liang CY; Wang LJ; Chen CP; Chen LF; Chen YH; Chen H
Biol Reprod; 2010 Sep; 83(3):387-95. PubMed ID: 20484742
[TBL] [Abstract][Full Text] [Related]
13. The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion.
Wang CC; Tsai MF; Hong TM; Chang GC; Chen CY; Yang WM; Chen JJ; Yang PC
Oncogene; 2005 Jun; 24(25):4081-93. PubMed ID: 15782117
[TBL] [Abstract][Full Text] [Related]
14. TP73 allelic expression in human brain and allele frequencies in Alzheimer's disease.
Li Q; Athan ES; Wei M; Yuan E; Rice SL; Vonsattel JP; Mayeux RP; Tycko B
BMC Med Genet; 2004 Jun; 5():14. PubMed ID: 15175114
[TBL] [Abstract][Full Text] [Related]
15. Genomic organization of human arylamine N-acetyltransferase Type I reveals alternative promoters that generate different 5'-UTR splice variants with altered translational activities.
Butcher NJ; Arulpragasam A; Goh HL; Davey T; Minchin RF
Biochem J; 2005 Apr; 387(Pt 1):119-27. PubMed ID: 15487985
[TBL] [Abstract][Full Text] [Related]
16. Nicotinic α5 receptor subunit mRNA expression is associated with distant 5' upstream polymorphisms.
Smith RM; Alachkar H; Papp AC; Wang D; Mash DC; Wang JC; Bierut LJ; Sadee W
Eur J Hum Genet; 2011 Jan; 19(1):76-83. PubMed ID: 20700147
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation study of the H37/RBM5 tumor suppressor gene from the 3p21.3 human lung cancer tumor suppressor locus.
Oh JJ; Boctor BN; Jimenez CA; Lopez R; Koegel AK; Taschereau EO; Phan DT; Jacobsen SE; Slamon DJ
Hum Genet; 2008 Feb; 123(1):55-64. PubMed ID: 18038152
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4.
Scherf DB; Sarkisyan N; Jacobsson H; Claus R; Bermejo JL; Peil B; Gu L; Muley T; Meister M; Dienemann H; Plass C; Risch A
Oncogene; 2013 Jul; 32(28):3329-38. PubMed ID: 22945651
[TBL] [Abstract][Full Text] [Related]
19. Single-nucleotide polymorphism rs4142441 and MYC co-modulated long non-coding RNA OSER1-AS1 suppresses non-small cell lung cancer by sequestering ELAVL1.
Xie W; Wang Y; Zhang Y; Xiang Y; Wu N; Wu L; Li C; Cai T; Ma X; Yu Z; Bai L; Li Y
Cancer Sci; 2021 Jun; 112(6):2272-2286. PubMed ID: 33113263
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.
Kikuchi S; Yamada D; Fukami T; Masuda M; Sakurai-Yageta M; Williams YN; Maruyama T; Asamura H; Matsuno Y; Onizuka M; Murakami Y
Clin Cancer Res; 2005 Apr; 11(8):2954-61. PubMed ID: 15837747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
